ONCOSEC MEDICAL Inc
DelistedCIK 1444307fmd_02J1007KP09PDD6ZAYR8MMQX3DManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Aug 01, 2007 to Jan 31, 2023, 53 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | – | – | – | – | – | – | – | – | – |
| Research and development | 3 | 6 | 13 | 15 | 12 | 17 | 18 | 25 | 34 | 26 |
| Operating income | (7) | (12) | (21) | (27) | (22) | (36) | (30) | (43) | (48) | (37) |
| Interest expense | – | – | – | – | – | – | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | – | – | – | – | 0 | 0 | 0 | 0 | (0) | 0 |
| Income before taxes | (7) | (12) | (21) | (27) | (21) | (39) | (30) | (43) | (48) | (38) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (1) | (2) | (3) |
| Net income from continuing operations | (7) | (12) | (21) | (27) | (21) | (39) | (30) | (42) | (45) | (34) |
| Net income | – | – | (21) | (27) | (21) | (39) | (30) | (42) | (45) | (34) |
| Net income to common shareholders | (7) | (12) | (21) | – | – | (134) | – | – | – | – |